Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Baudax Bio, Inc. (BXRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/06/2023 |
8-K
| Investor presentation |
| 09/29/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 08/24/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 08/21/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu... |
| 08/16/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
8-K
| Quarterly results |
| 07/17/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...|
Docs:
|
"Agreement and Plan of Merger, by and among Baudax Bio, Inc., Bounce Merger Sub I, Inc., Bounce Merger Sub II, LLC and TeraImmune, Inc.",
"Certificate of Designations of Series X Non-Voting Convertible Preferred Stock",
"Forbearance Agreement, by and among Baudax Bio, Inc, Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lender party hereto" |
|
| 06/28/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements on Form S-3, in the registration statements on Form S-8 and in the registration statements on Form S-1 of our report dated March 16, 2022, except for Note 4, as to which the date is June 28, 2023 with respect to the consolidated financial statements of Baudax Bio, Inc. /s/ KPMG LLP Philadelphia, Pennsylvania June 28, 2023",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements of Baudax Bio, Inc. on Form S­3 . 333-235408, 333-243488 and 333-253117), Form S­8 . 333-235377, 333-253118, 333-253120, 333-263606 and 333-263608) and Form S-1 . Nos. 333-266499, 333-268251 and 333-271161) of our report dated February 23, 2023, except for Note 4, as to which the date is June 28, 2023, on our audit of the financial statements as of December 31, 2022 and for the year then ended, and the retrospective adjustments to the 2021 financial statements discussed in Notes 1 and 3 to the financial statements.. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a g..." |
|
| 05/19/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/12/2023 |
8-K
| Quarterly results |
| 05/10/2023 |
8-K
| Investor presentation |
| 04/25/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...|
Docs:
|
"Amendment No. 5 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"Common Stock Purchase Warrant, in favor of MAM Eagle Lender, LLC",
"Amendment No. 5 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"Registration Rights Agreement between the Baudax Bio, Inc. and MAM Eagle Lender, LLC" |
|
| 03/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/03/2023 |
8-K
| Investor presentation |
| 02/23/2023 |
8-K
| Quarterly results |
| 01/24/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/09/2023 |
8-K
| Investor presentation |
| 12/30/2022 |
8-K
| Quarterly results |
| 12/05/2022 |
8-K
| Quarterly results |
| 12/01/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Amendment No. 3 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"Amendment No. 3 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto" |
|
| 11/30/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 11/08/2022 |
8-K
| Quarterly results |
| 10/28/2022 |
8-K
| Quarterly results |
| 09/20/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 08/31/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/24/2022 |
8-K
| Material Modifications to Rights of Security Holders, Financial Statements and Exhibits Interactive Data |
| 08/23/2022 |
8-K
| Investor presentation |
| 08/11/2022 |
8-K
| Quarterly results |
|
|
|